PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells

por Glodkowska-Mrowka, E, Manda-Handzlik, A, Stelmaszczyk-Emmel, A, Seferynska, I, Stoklosa, T, Przybylski, J, Mrowka, P
Publicado 2016